🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to see if Zemplar, a vitamin D medication, saf...
Status
Completed
Location
Stanford University Medical Center
Start Date
2002-01
Trial ID
NCT00053547
Treatments Being Tested
The purpose of this study is to determine if the combination of paclitaxel ...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2017-05-23
Trial ID
NCT03138720
Treatments Being Tested
Protocol HECT00306 aims to determine clinically appropriate doses of Hector...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00463021
Treatments Being Tested
Chemotherapy regimens for pancreatic cancer can now stabilize a patient's c...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2017-12-27
Trial ID
NCT03331562
Treatments Being Tested
A study to determine the effect of Zemplar on the regulation of serum calci...
Status
Completed
Location
Merced Heart Association
Start Date
2002-01
Trial ID
NCT00053378
This study is a exploratory comparison of the efficacy and safety of parica...
Status
Completed
Location
Site Ref # / Investigator 53794
Start Date
2009-10
Trial ID
NCT00990704
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety of paricalcit...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00701805
Treatments Being Tested
Prospective, non-randomized, multi-center study to assess the efficacy and ...
Status
Completed
Location
Site Ref # / Investigator 19391
Start Date
2007-09
Trial ID
NCT00537979
Treatments Being Tested
The PK and tolerability of paricalcitol after repeated intravenous administ...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00646932
Treatments Being Tested
To evaluate the survival benefit associated with Zemplar therapy as compare...
Status
Terminated
Location
Tuscaloosa Nephrology Associates
Start Date
2003-04
Trial ID
NCT00062699
Treatments Being Tested